Drug & device makers paid Pulmonary Disease providers $37.4M in 2025.

Every manufacturer payment to a provider is public record under the Sunshine Act. Here's the 2025 picture for Pulmonary Disease from the federal Open Payments database: who writes the checks, and where the money lands.